Actithera draws new investors to radiopharma drug pitch
BioPharma Drive: Drug Pricing
JULY 9, 2025
Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. in 2013 — the field has taken off since the success of Novartis’ prostate cancer treatment Pluvicto.
Let's personalize your content